Bambusa Therapeutics Files for IPO to Fund Drug Trials

Bambusa Therapeutics wants to raise money by selling shares to the public.

It plans to use the funds to test drugs for eczema and other inflammation disorders.

The trials will help researchers learn whether the drugs work.